3. Summary of Significant Accounting Policies (Details 8) (USD $)
|
0 Months Ended |
1 Months Ended |
3 Months Ended |
|
|
|
|
Sep. 03, 2014
|
Mar. 26, 2015
|
Mar. 20, 2015
|
Mar. 09, 2015
|
Mar. 04, 2015
|
Feb. 25, 2015
|
Nov. 17, 2014
|
Nov. 10, 2014
|
Sep. 26, 2014
|
Sep. 10, 2014
|
Aug. 28, 2014
|
Mar. 27, 2015
|
Mar. 17, 2015
|
Feb. 02, 2015
|
Jul. 07, 2014
|
Mar. 31, 2015
|
Mar. 11, 2015
|
Jan. 09, 2015
|
Mar. 31, 2015
|
Dec. 31, 2014
|
Nov. 10, 2011
|
Mar. 02, 2015
|
Feb. 26, 2015
|
Expected life (in months) |
36 months
|
6 months
|
6 months
|
6 months
|
6 months
|
6 months
|
12 months
|
10 months
|
12 months
|
12 months
|
6 months
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected volatility |
153.80%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
143.20%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
140.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
139.20%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
138.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
132.10%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
117.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
104.20%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
116.60%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
117.60%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
104.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
|
|
|
|
124.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
|
|
124.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
116.00%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
104.50%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
|
|
Risk-free interest rate |
0.99%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.07%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.12%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.10%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.11%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.12%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.05%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
|
|
|
|
0.31%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
|
|
0.31%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.58%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.875%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
|
|
Exercise price |
$ 0.35pbio_ExercisePriceWarrants
|
$ 0.18pbio_ExercisePriceWarrants
|
$ 0.20pbio_ExercisePriceWarrants
|
$ 0.20pbio_ExercisePriceWarrants
|
$ 0.17pbio_ExercisePriceWarrants
|
$ 0.10pbio_ExercisePriceWarrants
|
$ 0.17pbio_ExercisePriceWarrants
|
$ 0.13pbio_ExercisePriceWarrants
|
$ 0.16pbio_ExercisePriceWarrants
|
$ 0.13pbio_ExercisePriceWarrants
|
$ 0.14pbio_ExercisePriceWarrants
|
|
|
|
|
$ 0.25pbio_ExercisePriceWarrants
|
|
|
$ 0.25pbio_ExercisePriceWarrants
|
$ 0.25pbio_ExercisePriceWarrants
|
$ 0.81pbio_ExercisePriceWarrants
|
|
|
Fair value per warrant |
$ 0.24pbio_FairValuePerWarrant1
|
$ 0.20pbio_FairValuePerWarrant1
|
$ 0.20pbio_FairValuePerWarrant1
|
$ 0.13pbio_FairValuePerWarrant1
|
$ 0.17pbio_FairValuePerWarrant1
|
$ 0.28pbio_FairValuePerWarrant1
|
$ 0.20pbio_FairValuePerWarrant1
|
$ 0.23pbio_FairValuePerWarrant1
|
$ 0.19pbio_FairValuePerWarrant1
|
$ 0.17pbio_FairValuePerWarrant1
|
$ 0.15pbio_FairValuePerWarrant1
|
|
|
|
|
$ 0.20pbio_FairValuePerWarrant1
|
|
|
$ 0.20pbio_FairValuePerWarrant1
|
$ 0.15pbio_FairValuePerWarrant1
|
$ 0.54pbio_FairValuePerWarrant1
|
|
|
Transaction 1 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
6 months
|
6 months
|
6 months
|
12 months
|
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
142.60%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
143.30%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
111.70%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
117.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
0.06%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
0.07%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
0.12%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
$ 0.18pbio_ExercisePriceWarrants / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
$ 0.21pbio_ExercisePriceWarrants / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
$ 0.14pbio_ExercisePriceWarrants / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
$ 0.21pbio_ExercisePriceWarrants / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
$ 0.20pbio_FairValuePerWarrant1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
$ 0.19pbio_FairValuePerWarrant1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
$ 0.09pbio_FairValuePerWarrant1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
$ 0.18pbio_FairValuePerWarrant1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
|
|
|
|
Transaction 2 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
6 months
|
6 months
|
6 months
|
12 months
|
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
142.60%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
143.30%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
111.70%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
117.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
0.06%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
0.07%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
0.12%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
$ 0.14pbio_ExercisePriceWarrants / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
$ 0.17pbio_ExercisePriceWarrants / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
$ 0.14pbio_ExercisePriceWarrants / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
$ 0.21pbio_ExercisePriceWarrants / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
$ 0.22pbio_FairValuePerWarrant1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
$ 0.22pbio_FairValuePerWarrant1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
$ 0.09pbio_FairValuePerWarrant1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
$ 0.18pbio_FairValuePerWarrant1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
|
|
|
|
Conversion options revalued [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 months
|
2 months
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
144.60%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
142.20%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
|
144.60%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
|
|
437.50%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
0.80%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.17%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
0.18%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
|
0.17%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
|
|
0.01%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
0.01%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.17pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
$ 0.10pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
|
$ 0.17pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
|
|
$ 0.12pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
$ 0.10pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.18pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
$ 0.18pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
|
$ 0.18pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
|
|
$ 0.16pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
$ 0.26pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
Conversion options revalued [Member] | Transaction 1 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 months
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
114.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.12%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.14pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.12pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
|
Conversion options revalued [Member] | Transaction 2 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 months
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
114.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.12%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.14pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.12pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
|
Conversion options revalued One [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 months
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
148.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTwoMember
|
|
|
148.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTwoMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.18%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTwoMember
|
|
|
0.18%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTwoMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.14pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTwoMember
|
|
|
$ 0.14pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTwoMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.20pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTwoMember
|
|
|
$ 0.20pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTwoMember
|
|
|
|
|
Conversion options revalued Two [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 months
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
132.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedThreeMember
|
|
|
132.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedThreeMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.15%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedThreeMember
|
|
|
0.15%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedThreeMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.17pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedThreeMember
|
|
|
$ 0.17pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedThreeMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.18pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedThreeMember
|
|
|
$ 0.18pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedThreeMember
|
|
|
|
|
Conversion options revalued Three [Member] | Transaction 1 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 months
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
146.00%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
146.00%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.07%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
0.07%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.20pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
$ 0.20pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.14pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
$ 0.14pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Conversion options revalued Three [Member] | Transaction 2 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 months
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
146.00%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
146.00%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.07%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
0.07%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.19pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
$ 0.19pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.16pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
$ 0.16pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Conversion options revalued Four [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 months
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFiveMember
|
|
|
149.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFiveMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFiveMember
|
|
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFiveMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.14pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFiveMember
|
|
|
$ 0.14pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFiveMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.19pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFiveMember
|
|
|
$ 0.19pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFiveMember
|
|
|
|
|
Conversion options revalued Five [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 months
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150.50%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSixMember
|
|
|
150.50%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSixMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSixMember
|
|
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSixMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.19pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSixMember
|
|
|
$ 0.19pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSixMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.16pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSixMember
|
|
|
$ 0.16pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSixMember
|
|
|
|
|
Conversion options revalued Six [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 months
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149.80%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSevenMember
|
|
|
149.80%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSevenMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSevenMember
|
|
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSevenMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.21pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSevenMember
|
|
|
$ 0.21pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSevenMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.15pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSevenMember
|
|
|
$ 0.15pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSevenMember
|
|
|
|
|
Conversion options revalued Seven [Member] | Transaction 1 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 months
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149.30%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
149.30%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.21pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
$ 0.21pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.16pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
$ 0.16pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Conversion options revalued Seven [Member] | Transaction 2 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 months
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149.30%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
149.30%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.20pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
$ 0.20pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.16pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
$ 0.16pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Conversion options revalued Eight [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 months
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
147.20%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedNineMember
|
|
|
147.20%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedNineMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedNineMember
|
|
|
0.08%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedNineMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.21pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedNineMember
|
|
|
$ 0.21pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedNineMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.15pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedNineMember
|
|
|
$ 0.15pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedNineMember
|
|
|
|
|
Conversion options revalued Nine [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 months
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
144.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTenMember
|
|
|
144.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTenMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.07%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTenMember
|
|
|
0.07%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTenMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.18pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTenMember
|
|
|
$ 0.18pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTenMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.17pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTenMember
|
|
|
$ 0.17pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTenMember
|
|
|
|
|
Conversion options revalued Ten [Member] | Transaction 1 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 months
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
144.30%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
144.30%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.06%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
0.06%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.19pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
$ 0.19pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.17pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
$ 0.17pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Conversion options revalued Ten [Member] | Transaction 2 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 months
|
|
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
144.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
144.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.06%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
0.06%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.14pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
$ 0.14pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.19pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
$ 0.19pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|